Neuropilin
From Proteopedia
(Difference between revisions)
Line 18: | Line 18: | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
- | *NRP-1 | + | *NRP-1; Domains - B1 273-427, MAM 628-813, A2B1B2 141-586 |
**[[1kex]], [[2qqi]] – hNRP-1 B1 domain – human<br /> | **[[1kex]], [[2qqi]] – hNRP-1 B1 domain – human<br /> | ||
**[[4rn5]] – hNRP-1 B1 domain<br /> | **[[4rn5]] – hNRP-1 B1 domain<br /> | ||
+ | **[[7o1n]] – hNRP-1 B1 domain (mutant)<br /> | ||
**[[5l73]] – hNRP-1 MAM domain<br /> | **[[5l73]] – hNRP-1 MAM domain<br /> | ||
**[[2qqm]] - hNRP-1 A2+B1+B2 domains<br /> | **[[2qqm]] - hNRP-1 A2+B1+B2 domains<br /> | ||
**[[4deq]] - hNRP-1 B1 domain + VEGF-A heparin-binding domain<br /> | **[[4deq]] - hNRP-1 B1 domain + VEGF-A heparin-binding domain<br /> | ||
**[[6tkk]] - hNRP-1 B1 domain + VEGF-A peptide<br /> | **[[6tkk]] - hNRP-1 B1 domain + VEGF-A peptide<br /> | ||
- | **[[ | + | **[[7p5u]] - hNRP-1 B1 domain + VEGF-B peptide<br /> |
+ | **[[7jjc]] - hNRP-1 B1 domain + SARS-CoV-2 peptide<br /> | ||
**[[2qqn]] - hNRP-1 B1 domain + VEGF-blocking antibody | **[[2qqn]] - hNRP-1 B1 domain + VEGF-blocking antibody | ||
**[[5c7g]] – hNRP-1 B1 domain + bicine<br /> | **[[5c7g]] – hNRP-1 B1 domain + bicine<br /> | ||
Line 41: | Line 43: | ||
*NRP-2; Domains - CUB 27-145; A2 145-275; B1 275-430; B2 431-595 | *NRP-2; Domains - CUB 27-145; A2 145-275; B1 275-430; B2 431-595 | ||
+ | **[[7t4s]] – hNRP-2 + Herpes virus envelope + antibody – Cryo EM<br /> | ||
**[[4qdq]], [[4qds]], [[2qqj]] - hNRP-2 B1+B2 domains<br /> | **[[4qdq]], [[4qds]], [[2qqj]] - hNRP-2 B1+B2 domains<br /> | ||
**[[5dq0]] – hNRP-2 B1 domain<br /> | **[[5dq0]] – hNRP-2 B1 domain<br /> |
Current revision
|
3D Structures of Neuropilin
Updated on 16-July-2023
References
- ↑ Romeo PH, Lemarchandel V, Tordjman R. Neuropilin-1 in the immune system. Adv Exp Med Biol. 2002;515:49-54. PMID:12613542
- ↑ Pellet-Many C, Frankel P, Jia H, Zachary I. Neuropilins: structure, function and role in disease. Biochem J. 2008 Apr 15;411(2):211-26. doi: 10.1042/BJ20071639. PMID:18363553 doi:http://dx.doi.org/10.1042/BJ20071639